Top Authors

• Most frequent coverage on IVGN

• 
  Market Folly (1969 followers)

  • A Look at D.E. Shaw's Q408 Holdings: Just for Fun (Wed, Apr 22)
  • Hedge Fund Tracking: Barry Rosenstein's Jana Partners, Q3 2008 (Wed, Dec 24)

  More by Market Folly on IVGN »
• 
  Centient Biotech Investor (10 followers)

  • Biotech Day In Review: Osiris Stem Cells Treatment Has Unexpected Results (Thu, Feb 15)
  • Top Picks for 2007 from JPMorgan HealthCare Analysts (Fri, Jan 12)

  More by Centient Biotech Investor on IVGN »
• 
  Stockerblog (439 followers)

  • Nine Stem Cell Stocks to Add to Your Portfolio (Tue, Oct 2)
  • Investing in Stem Cell Stocks: Growth Industry of the Future? (Wed, Feb 21)

  More by Stockerblog on IVGN »

• Most followed authors on IVGN

• 
  Don Dion (2760 followers)

  • Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF? (Fri, May 9)

  More by Don Dion on IVGN »
• 
  Market Folly (1969 followers)

  • A Look at D.E. Shaw's Q408 Holdings: Just for Fun (Wed, Apr 22)
  • Hedge Fund Tracking: Barry Rosenstein's Jana Partners, Q3 2008 (Wed, Dec 24)

  More by Market Folly on IVGN »
• 
  Mike Havrilla (1925 followers)

  • Biotech Buying Binge About to Begin? (Wed, Jul 23)

  More by Mike Havrilla on IVGN »

• Newest authors on IVGN

• 
  Market Folly (1969 followers)

  • A Look at D.E. Shaw's Q408 Holdings: Just for Fun (Wed, Apr 22)
  • Hedge Fund Tracking: Barry Rosenstein's Jana Partners, Q3 2008 (Wed, Dec 24)

  More by Market Folly on IVGN »
• 
  Brian Dean (2 followers)

  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit (Thu, Mar 12)

  More by Brian Dean on IVGN »
• 
  Don Dion (2760 followers)

  • Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF? (Fri, May 9)

  More by Don Dion on IVGN »

• Most commented on IVGN

• 
  Stockerblog (439 followers)

  • Nine Stem Cell Stocks to Add to Your Portfolio (Tue, Oct 2)
  • Investing in Stem Cell Stocks: Growth Industry of the Future? (Wed, Feb 21)

  More by Stockerblog on IVGN »
• 
  Brian Dean (2 followers)

  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit (Thu, Mar 12)

  More by Brian Dean on IVGN »
• 
  Market Folly (1969 followers)

  • A Look at D.E. Shaw's Q408 Holdings: Just for Fun (Wed, Apr 22)
  • Hedge Fund Tracking: Barry Rosenstein's Jana Partners, Q3 2008 (Wed, Dec 24)

  More by Market Folly on IVGN »